KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Interest & Investment Income (2020 - 2025)

Bionano Genomics' Interest & Investment Income history spans 6 years, with the latest figure at $268000.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 28.72% year-over-year to $268000.0; the TTM value through Sep 2025 reached $1.1 million, down 65.42%, while the annual FY2024 figure was $2.1 million, 36.54% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $268000.0 at Bionano Genomics, down from $277000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.2 million in Q4 2023 and bottomed at $29000.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $290000.0 (2025), against an average of $420526.3.
  • The largest annual shift saw Interest & Investment Income skyrocketed 1403.45% in 2022 before it plummeted 81.08% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $84000.0 in 2021, then skyrocketed by 815.48% to $769000.0 in 2022, then soared by 54.62% to $1.2 million in 2023, then tumbled by 81.08% to $225000.0 in 2024, then grew by 19.11% to $268000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Interest & Investment Income are $268000.0 (Q3 2025), $277000.0 (Q2 2025), and $290000.0 (Q1 2025).